As an infrastructure at the German Center for Infection Research (DZIF), the Clinical Trial Unit tracks DZIF's study activities in the “Healex Site Management System (SMS)”. Studies are sorted by indication and are continuously updated.

The study register has recently been expanded to include the category “COVID-19”. For the first time, not only DZIF study activities are presented here: In order to provide a comprehensive overview in the current pandemic situation of planned and already active COVID-19 studies in Germany, the Clinical Trial Unit is cooperating with researchers from various German Centers for Health Research and other networks.

For researchers: If your study is not yet included in our portal, please contact the project management of the Clinical Trial Unit (angela.steinbach@uk-koeln.de or vassiliki.dimitriou@uk-koeln.de).

CoCoNut

AcronymISRCTNEudraCTNCT (clinicaltrials.gov)DRKS
CoCoNutentfälltNCT01821456entfällt

Cologne Cohort of Neutropenic Patients

Status: Active

Purpose / Objectives

Primary Outcome

Prospective cohort on the outcome of neutropenic patients (risk factors, therapy, treatment results).

Secondary Outcomes

Prospective cohort on the outcome of neutropenic patients (risk factors, therapy, treatment results).

Diagnosis

Neutropenia

Target population

Inclusion criteria

All patients neutropenic for at least two consecutive days.

Exclusion criteria

none

Study design

  • Single center
  • Prospective

Documents (password protected)

Responsibilities in overall study

Infektiologie II

Sponsor representative

Univ.-Prof. Dr. med. Oliver A. Cornely

Univ.-Prof. Dr. med. Jörg Janne Vehreschild

National Coordinating Investigator

Univ.-Prof. Dr. med. Jörg Janne Vehreschild

Project management

Infektiologie II

Dr. Sebastian Wingen-Heimann

Data management

Infektiologie II

Dr. Sebastian Wingen-Heimann

Database development

Infektiologie II

Univ.-Prof. Dr. med. Jörg Janne Vehreschild